Related Experiment Videos
Lung transplantation: management and complications
P N Chhajed1, M Tamm, M A Malouf
1The Lung Transplant Unit, St Vincent's Hospital, NSW, Sydney, Australia.
The Indian Journal of Chest Diseases & Allied Sciences
|February 16, 2002
Summary
Lung transplantation treats end-stage lung diseases. Management focuses on preventing infections and chronic rejection, like obliterative bronchiolitis, to improve long-term survival after transplant.
Area of Science:
- Medicine
- Pulmonology
- Transplantation
Background:
- Lung transplantation is a vital treatment for end-stage lung diseases such as emphysema, cystic fibrosis, and pulmonary hypertension.
- Despite advancements, acute rejection and infections are common early complications in lung transplant recipients.
- Long-term survival is significantly impacted by chronic rejection, primarily obliterative bronchiolitis (OB).
Purpose of the Study:
- To outline the critical aspects of postoperative care for lung transplant recipients.
- To discuss strategies for managing long-term complications following lung transplantation.
- To emphasize the importance of addressing infections and chronic rejection.
Main Methods:
- Review of current clinical practices in lung transplant management.
- Analysis of common complications including infections and rejection.
- Discussion of immunosuppressive therapy and its side effects.
Main Results:
- Acute rejection and infections necessitate prompt diagnosis and treatment post-transplant.
- Immunosuppressive agents carry significant long-term side effects, including renal toxicity and malignancy.
- Obliterative bronchiolitis remains the leading cause of mortality in long-term lung transplant survivors.
Conclusions:
- Effective postoperative and long-term management is crucial for lung transplant recipients.
- Vigilance against infections and chronic rejection is paramount for improving patient outcomes.
- Balancing immunosuppression with the risk of side effects is a key challenge in lung transplant care.